GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol Myers Squibb's anti-PD-1 therapy, as ...

ALEC-04 is under clinical development by Alentis Therapeutics and currently in Phase II for Nasopharyngeal Cancer.

While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee ...

COM-701 is under clinical development by Compugen and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...

The larynx is the tube that connects the bottom of the throat to the windpipe (trachea). It is divided into three sections called the supraglottis, glottis, and subglottis. Structures in the larynx ...

Head and neck squamous cell carcinoma (HNSCC) originates from the mucosal epithelium of the oral cavity, pharynx, and larynx, and is marked by high rates of recurrence and metastasis. Calcium ...

First-of-its-kind research looking at survival rates for patients with incurable larynx cancer has been published. The research, led by cancer doctors and scientists at Newcastle University and the ...

Van Zunderck suggested calling those with channel for built-in video as third-generation SADs (3). Currently, we know that proper head and neck position is essential to achieve adequate visualisation ...